Literature DB >> 26515428

A Pilot Study Assessing ECG versus ECHO Ventriculoventricular Optimization in Pediatric Resynchronization Patients.

Rajesh Punn1, Debra Hanisch1, Kara S Motonaga1, David N Rosenthal1, Scott R Ceresnak1, Anne M Dubin1.   

Abstract

INTRODUCTION: Cardiac resynchronization therapy indications and management are well described in adults. Echocardiography (ECHO) has been used to optimize mechanical synchrony in these patients; however, there are issues with reproducibility and time intensity. Pediatric patients add challenges, with diverse substrates and limited capacity for cooperation. Electrocardiographic (ECG) methods to assess electrical synchrony are expeditious but have not been extensively studied in children. We sought to compare ECHO and ECG CRT optimization in children.
METHODS: Prospective, pediatric, single-center cross-over trial comparing ECHO and ECG optimization with CRT. Patients were assigned to undergo either ECHO or ECG optimization, followed for 6 months, and crossed-over to the other assignment for another 6 months. ECHO pulsed-wave tissue Doppler and 12-lead ECG were obtained for 5 VV delays. ECG optimization was defined as the shortest QRSD and ECHO optimization as the lowest dyssynchrony index. ECHOs/ECGs were interpreted by readers blinded to optimization technique. After each 6 month period, these data were collected: ejection fraction, velocimetry-derived cardiac index, quality of life, ECHO-derived stroke distance, M-mode dyssynchrony, study cost, and time. Outcomes for each optimization method were compared.
RESULTS: From June 2012 to December 2013, 19 patients enrolled. Mean age was 9.1 ± 4.3 years; 14 (74%) had structural heart disease. The mean time for optimization was shorter using ECG than ECHO (9 ± 1 min vs. 68 ± 13 min, P < 0.01). Mean cost for charges was $4,400 ± 700 less for ECG. No other outcome differed between groups.
CONCLUSION: ECHO optimization of synchrony was not superior to ECG optimization in this pilot study. ECG optimization required less time and cost than ECHO optimization.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac resynchronization therapy; optimization; pediatric

Mesh:

Year:  2015        PMID: 26515428     DOI: 10.1111/jce.12863

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

Review 1.  Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Authors:  Scott Anjewierden; Peter F Aziz
Journal:  Curr Cardiol Rep       Date:  2018-07-18       Impact factor: 2.931

Review 2.  Cardiac resynchronization therapy in congenital heart disease.

Authors:  Jan Janoušek; Peter Kubuš
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-05-25

3.  Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization Therapy.

Authors:  Angela W C Lee; Andrew Crozier; Eoin R Hyde; Pablo Lamata; Michael Truong; Manav Sohal; Thomas Jackson; Jonathan M Behar; Simon Claridge; Anoop Shetty; Eva Sammut; Gernot Plank; Christopher Aldo Rinaldi; Steven Niederer
Journal:  J Cardiovasc Electrophysiol       Date:  2017-01-14

4.  Ventricular dyssynchrony assessment using ultra-high frequency ECG technique.

Authors:  Pavel Jurak; Josef Halamek; Jaroslav Meluzin; Filip Plesinger; Tereza Postranecka; Jolana Lipoldova; Miroslav Novak; Vlastimil Vondra; Ivo Viscor; Ladislav Soukup; Petr Klimes; Petr Vesely; Josef Sumbera; Karel Zeman; Roshini S Asirvatham; Jason Tri; Samuel J Asirvatham; Pavel Leinveber
Journal:  J Interv Card Electrophysiol       Date:  2017-07-10       Impact factor: 1.900

5.  Improvement of increased cQTd is associated with heart function in patients with ischemic heart failure.

Authors:  Hui Guo; Miao Wang; Juan Zhao; Jing Liu; Jie-Mei Yang
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

Review 6.  The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.

Authors:  Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Christos Damaskos; Antonios Athanasiou; Efthimios Livanis; Vassilis Voudris
Journal:  Open Cardiovasc Med J       Date:  2017-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.